18 to be exact. Just on TBI clearence of safety of drug shortly makes this a 80-100 million market cap. Thats not including now that it is superior than ace inhibitors. Still significantly undervalued
Ann: Drug Candidate Demonstrates Significant Cardioprotection, page-26
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.010(8.33%) |
Mkt cap ! $20.04M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.0¢ | $72.78K | 624.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 302090 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| NYR (ASX) Chart |